JNJ-64530440, a novel capsid assembly modulator: single- and multiple-ascending dose safety, tolerability and pharmacokinetics in healthy volunteers

被引：7
|
作者：
Kakuda, Thomas [1 ]
Yogaratnam, Jeysen [1 ]
Westland, Christopher [1 ]
Gane, Edward [2 ]
Schwabe, Christian [3 ]
Patel, Megha [1 ]
Talloen, Willem [4 ]
Lenz, Oliver [4 ]
van Remoortere, Pieter [5 ]
机构：
[1] Janssen BioPharma Inc, San Francisco, CA USA
[2] Univ Auckland, New Zealand Liver Transplant Unit, Auckland, New Zealand
[3] Auckland Clin Studies, Auckland, New Zealand
[4] Janssen Pharmaceut NV, Beerse, Belgium
[5] Janssen Pharmaceut, Titusville, FL USA
来源：
JOURNAL OF HEPATOLOGY | 2019年 / 70卷 / 01期
关键词：
D O I：
10.1016/S0618-8278(19)30925-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-180
引用
收藏
页码：E469 / E469
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetics, safety and tolerability of single- and multiple-ascending doses of JNJ-64530440, a novel hepatitis B virus capsid assembly modulator, in healthy volunteers
    Kakuda, Thomas N.
    Yogaratnam, Jeysen Z.
    Westland, Christopher
    Gane, Edward J.
    Schwabe, Christian
    Vuong, Jennifer
    Patel, Megha
    Snoeys, Jan
    Talloen, Willem
    Lenz, Oliver
    Fry, John
    Chanda, Sushmita
    van Remoortere, Pieter
    ANTIVIRAL THERAPY, 2021, 26 (1-2) : 13 - 24
  • [2] Single-Dose Pharmacokinetics (PK),Safety and Tolerability of JNJ-64530440 (JNJ-0440), a Novel Hepatitis B Virus (HBV) Capsid Assembly Modulator (CAM), in Healthy Volunteers (HV)
    Kakuda, Thomas
    Yogaratnam, Jeysen
    Gane, Edward J.
    Schwabe, Christian
    Westland, Christopher
    Vuong, Jennifer
    Talloen, Willem
    Lenz, Oliver
    Fry, John
    Chanda, Sushmita
    Van Remoortere, Pieter
    HEPATOLOGY, 2018, 68 : 261A - 261A
  • [3] Safety, Tolerability, and Pharmacokinetics of Single- and Multiple-Ascending Doses of Sunobinop in Healthy Participants
    Cipriano, Alessandra
    Kapil, Ram P.
    Zhou, Mingyan
    Shet, Manjunath S.
    Whiteside, Garth T.
    Willsie, Sandra K.
    Harris, Stephen C.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2024, 13 (07): : 790 - 800
  • [4] JNJ-64530440 (JNJ-0440), A NOVEL CLASS N CAPSID ASSEMBLY MODULATOR (CAM-N): SAFETY, TOLERABILITY, PHARMACOKINETICS (PK), AND ANTIVIRAL ACTIVITY OF MULTIPLE ASCENDING DOSES IN PATIENTS (PTS) WITH CHRONIC HEPATITIS B (CHB)
    Gane, Edward J.
    Schwabe, Christian
    Lenz, Oliver
    Verbinnen, Thierry
    Talloen, Willem
    Kakuda, Thomas
    Westland, Christopher
    Patel, Megha
    Yogaratnam, Jeysen
    Van Remoortere, Pieter
    HEPATOLOGY, 2019, 70 : 61A - 61A
  • [5] Single- and multiple-ascending dose studies to evaluate the safety, tolerability, and pharmacokinetics of daclatasvir and asunaprevir in healthy male Japanese subjects
    Shiozaki, Tomomi
    Ueno, Takayo
    Nagashima, Hirotaka
    Yamahira, Naomi
    Hiraoka, Masaki
    Eley, Tim
    Bifano, Marc
    Bertz, Richard J.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2015, 53 (04) : 292 - 300
  • [6] Safety, Tolerability and Pharmacokinetics of JNJ-56136379, a Novel HBV Capsid Assembly Modulator, in Healthy Subjects.
    Yogaratnam, Jeysen Z.
    Vandenbossche, Joris J.
    Jessner, Wolfgang
    Van den Boer, Maarten
    Bieweng, Jeike
    Rasschaert, Freya
    Vistuer, Christelle
    Janssen, Katrien
    Smyej, Ilham
    Verstraete, Dominique
    Berke, Jan Martin
    Vandyck, Koen
    Chanda, Sushmita
    Fry, John
    HEPATOLOGY, 2016, 64 : 930A - 931A
  • [7] Pharmacokinetics, Safety and Tolerability of JNJ-56136379, a Novel Hepatitis B Virus Capsid Assembly Modulator, in Healthy Subjects
    Vandenbossche, Joris
    Jessner, Wolfgang
    van den Boer, Maarten
    Biewenga, Jeike
    Berke, Jan Martin
    Talloen, Willem
    De Zwart, Loeckie
    Snoeys, Jan
    Yogaratnam, Jeysen
    ADVANCES IN THERAPY, 2019, 36 (09) : 2450 - 2462
  • [8] Pharmacokinetics, Safety and Tolerability of JNJ-56136379, a Novel Hepatitis B Virus Capsid Assembly Modulator, in Healthy Subjects
    Joris Vandenbossche
    Wolfgang Jessner
    Maarten van den Boer
    Jeike Biewenga
    Jan Martin Berke
    Willem Talloen
    Loeckie De Zwart
    Jan Snoeys
    Jeysen Yogaratnam
    Advances in Therapy, 2019, 36 : 2450 - 2462
  • [9] Safety, antiviral activity and pharmacokinetics of JNJ-64530440, a novel capsid assembly modulator, as 4 week monotherapy in treatment-naive patients with chronic hepatitis B virus infection
    Gane, Ed J.
    Schwabe, Christian
    Berliba, Elina
    Tangkijvanich, Pisit
    Jucov, Alina
    Ghicavii, Nelea
    Verbinnen, Thierry
    Lenz, Oliver
    Talloen, Willem
    Kakuda, Thomas N.
    Westland, Chris
    Patel, Megha
    Yogaratnam, Jeysen Z.
    Dragone, Leonard
    Van Remoortere, Pieter
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (04) : 1102 - 1110
  • [10] Correction to: Pharmacokinetics, Safety and Tolerability of JNJ-56136379, a Novel Hepatitis B Virus Capsid Assembly Modulator, in Healthy Subjects
    Joris Vandenbossche
    Wolfgang Jessner
    Maarten van den Boer
    Jeike Biewenga
    Jan Martin Berke
    Willem Talloen
    Loeckie De Zwart
    Jan Snoeys
    Koen Vandyck
    John Fry
    Jeysen Yogaratnam
    Advances in Therapy, 2020, 37 : 1703 - 1703
12345